These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2947643)

  • 21. Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1. Implications for the mechanism of profibrinolytic action of activated protein C.
    Rezaie AR
    J Biol Chem; 2001 May; 276(19):15567-70. PubMed ID: 11264280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of protein C in endotoxin-induced release of plasminogen activator inhibitor from endothelial cell].
    Okajima K; Koga S; Nakagaki T; Okabe H; Funatsu A; Takatsuki K
    Nihon Ketsueki Gakkai Zasshi; 1989 Nov; 52(7):1159-64. PubMed ID: 2618561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2.
    Thorsen S; Philips M; Selmer J; Lecander I; Astedt B
    Eur J Biochem; 1988 Jul; 175(1):33-9. PubMed ID: 3136015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus.
    Braaten JV; Handt S; Jerome WG; Kirkpatrick J; Lewis JC; Hantgan RR
    Blood; 1993 Mar; 81(5):1290-9. PubMed ID: 8443390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3.
    Heeb MJ; España F; Geiger M; Collen D; Stump DC; Griffin JH
    J Biol Chem; 1987 Nov; 262(33):15813-6. PubMed ID: 2824468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.
    Nguyen G; Horellou MH; Kruithof EK; Conard J; Samama MM
    Blood; 1988 Aug; 72(2):601-5. PubMed ID: 3135860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombin Provokes Degranulation of Platelet α-Granules Leading to the Release of Active Plasminogen Activator Inhibitor-1 (PAI-1).
    Huebner BR; Moore EE; Moore HB; Stettler GR; Nunns GR; Lawson P; Sauaia A; Kelher M; Banerjee A; Silliman CC
    Shock; 2018 Dec; 50(6):671-676. PubMed ID: 29280928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation.
    Cariou R; Tobelem G; Bellucci S; Soria J; Soria C; Maclouf J; Caen J
    Thromb Haemost; 1988 Aug; 60(1):54-8. PubMed ID: 2847352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
    Lawrence D; Strandberg L; Grundström T; Ny T
    Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors.
    Kirchheimer JC; Remold HG
    Blood; 1989 Sep; 74(4):1396-402. PubMed ID: 2548640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein C inhibitor secreted from activated platelets efficiently inhibits activated protein C on phosphatidylethanolamine of platelet membrane and microvesicles.
    Nishioka J; Ning M; Hayashi T; Suzuki K
    J Biol Chem; 1998 May; 273(18):11281-7. PubMed ID: 9556620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of human endothelial cell-type plasminogen activator inhibitor (PAI-1) by negatively charged phospholipids.
    Lambers JW; Cammenga M; König BW; Mertens K; Pannekoek H; van Mourik JA
    J Biol Chem; 1987 Dec; 262(36):17492-6. PubMed ID: 3121598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.
    Perides G; Noring R; Klempner MS
    Biochem Biophys Res Commun; 1996 Feb; 219(3):690-5. PubMed ID: 8645243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro.
    de Fouw NJ; Haverkate F; Bertina RM; Koopman J; van Wijngaarden A; van Hinsbergh VW
    Blood; 1986 Apr; 67(4):1189-92. PubMed ID: 2937472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
    Sakata Y; Okada M; Noro A; Matsuda M
    J Biol Chem; 1988 Feb; 263(4):1960-9. PubMed ID: 3123483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelets stimulate endothelial cells to synthesize type 1 plasminogen activator inhibitor. Evaluation of the role of transforming growth factor beta.
    Slivka SR; Loskutoff DJ
    Blood; 1991 Mar; 77(5):1013-9. PubMed ID: 1825286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High affinity binding sites for activated protein C and protein C on cultured human umbilical vein endothelial cells. Independent of protein S and distinct from known ligands.
    Bangalore N; Drohan WN; Orthner CL
    Thromb Haemost; 1994 Sep; 72(3):465-74. PubMed ID: 7855799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma factor V activation is prevented by activated protein C in the presence of phospholipid vesicles, not platelets.
    Solymoss S; Nguyen KT
    Thromb Haemost; 1993 Feb; 69(2):124-9. PubMed ID: 8456424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C.
    Camire RM; Kalafatis M; Simioni P; Girolami A; Tracy PB
    Blood; 1998 Apr; 91(8):2818-29. PubMed ID: 9531592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated platelets increase fibrinolysis of mesenchymal progenitor cells.
    Agis H; Kandler B; Fischer MB; Watzek G; Gruber R
    J Orthop Res; 2009 Jul; 27(7):972-80. PubMed ID: 19030175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.